Pulmonary embolism after major abdominal surgery in gynecologic oncology

Obstetrics and Gynecology

Volumn 107, Issue 3, 2006, Pages 666-671

  Martino, Martin A ^a   Borges, Elana ^b   Williamson, Eva ^b   Siegfried, Sylvia ^b   Cantor, Alan B ^b   Lancaster, Johnathan ^b   Roberts, William S ^b   Hoffman, Mitchel S ^b  

^a LEHIGH VALLEY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; COLON CANCER; COMPRESSION THERAPY; FEMALE; GYNECOLOGIC CANCER; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVIX CANCER; UTERINE TUBE CARCINOMA; UTERUS CANCER; VAGINA CANCER; VENOUS THROMBOEMBOLISM; VULVA CANCER;

ABDOMINAL CAVITY; COHORT STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INCIDENCE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33646814962     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000200046.28199.ae     Document Type: Article

References (15)

1. Martino MA, Williamson E, Siegfried S, Cardosi RJ, Canot AB, Hoffman MS, et al. Diagnosing pulmonary embolism: Experience with spiral CT pulmonary angiography in gynecologic oncology. Gynecol Oncol 2005;98:289-93.
2. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep venous thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000;160:761-8.
3. Mantel N, Byar D. Evaluation of response time data involving transient states: an illustration using heart-transplant data. J Am Stat Assoc 1974;69:81-6.
4. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using Medicare claims data. Medicine 1999;78:285-91.
5. Clarke-Pearson DL, Coleman RE, Synan IS, Hinshaw W, Creasman WT. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol 1983;145:606-13.
6. Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creaseman ET. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignany. Obstet Gynecol 1984;63:92-8.
7. Clarke-Pearson DL, Synan IS, Dodge R, Soper JT, Berchuck A, Coleman RE. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol 1993;168:1146-54.
8. Maxwell GL, Synan I, Dodge R, Carroll B, Clarke-Pearson DL. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 2001;98:989-95.
9. Clarke-Pearson DL, Dodge RK, Synan I, McClelland RC, Maxwell GL. Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression. Obstet Gynecol 2003;101:157-63.
10. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126 suppl:338S-400S.
11. Woolson ST, Watt JM. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement: a prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J Bone Joint Surg Am 1991;73:507-12.
12. Ailawadi M, Del Priore G. A comparison of thromboembolic prophylaxis in gynecologic oncology patients. Int J Gynecol Cancer 2001;11:354-8.
13. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-80.
14. Ratner M. Genentech discloses safety concerns over avastin. Nat Biotechnol 2004;22:1198.
15. Wun T, Law L, Harvey D, Sieracki B, Scudder SA, Ryu JK. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation and erythropoietin. Cancer 2003;98:1514-20.